Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Trial combining British and Russian COVID-19 vaccines could begin in February

AstraZeneca announced the clinical trial programme in December

- PMLiVE

Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions

Possible adverse events reported at a vaccination centre in the US

- PMLiVE

My Journey Into MedComms #LucidLife

In NetworkPharma’s latest career guide for wannabe account managers, Tessa Rowland, Senior Account Executive, discusses her journey into the varied and fast-paced world of medical communications.

Lucid Group Communications Limited

- PMLiVE

David Eatwell joins Porterhouse Insights

Eatwell joins the Porterhouse team from Cello Health Insight

- PMLiVE

Relics from the past

Terms that were once perfectly descriptive now only serve to tell us how the world has changed

EU flag

EU proposes vaccine-sharing mechanism with low-income countries

Mechanism could provide low-income countries with early access to COVID-19 vaccines

- PMLiVE

Lilly partners with Merus on development of bispecific antibodies for cancer

As part of the deal, Merus could receive a total of up to around $1.6bn for three products

- PMLiVE

WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”

Tedros Adhanom Ghebreyesus warns bilateral deals could threaten COVAX facility

- PMLiVE

Valneva set to begin commercial manufacturing of COVID-19 vaccine within days

Vaccine could be in use in Britain by September

- PMLiVE

Research Partnership appoints Hannah Osborn to MedTech director role

Osborne has previously worked at Ipsos and IQVIA

- PMLiVE

Sourcing R&D innovation: why pharma companies need to evolve their business models

Recent years have seen a significant shift in drug development to specialty areas

- PMLiVE

GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours

Investigational PD-1 inhibitor is being studied in mismatch repair-deficient solid tumours

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links